Crossref

1. Evaluation of hepatosteatosis in patients with chronic hepatitis B virus infection

- Merve Sefa Sayar

- Dilek Bulut

- Ali Acar

2. A circulating microRNA signature as noninvasive diagnostic and prognostic biomarkers for nonalcoholic steatohepatitis

- Jie Liu

- Yue Xiao

- Xikun Wu

- Lichun Jiang

- Shurong Yang

- Zhiming Ding

- Zhuo Fang

- Haiqing Hua

- Mark Stephen Kirby

- Jianyong Shou

3. Clinical and Laboratory Characteristics of Normal Weight and Obese Individuals with Non-Alcoholic Fatty Liver Disease

- Anca Trifan

- Adrian Rotaru

- Remus Stafie

- Ermina Stratina

- Sebastian Zenovia

- Robert Nastasa

- Laura Huiban

- Tudor Cuciureanu

- Cristina Muzîca

- Stefan Chiriac

- Irina Gîrleanu

- Ana-Maria Sîngeap

- Catalin Sfarti

- Camelia Cojocariu

- Carol Stanciu

4. Is Aspartate Aminotransferase to Platelet Ratio Index a Better Noninvasive Score for Predicting Advanced Fibrosis in Nonalcoholic Fatty Liver Disease Patients?

- Priyansh D Bhayani

- Sarojini A Parameswaran

- Kallippatti R Palaniswamy

- Paramasivan Piramanayagam

- Natarajan Murugan

5. Serum proteome assessment in nonalcoholic fatty liver disease in children: a preliminary study

- Paweł Małecki

- Joanna Tracz

- Magdalena Łuczak

- Magdalena Figlerowicz

- Katarzyna Mazur-Melewska

- Wojciech Służewski

- Anna Mania

6. FIB-4 is closer to FibroScan screen results to detecting advanced liver fibrosis and maybe facilitates NAFLD warning

- Yuping Ding

- Zuoyu Wang

- Haiyan Niu

- Quanjun Deng

- Yanan Wang

- Shihai Xia

7. High FIB4 index is an independent risk factor of diabetic kidney disease in type 2 diabetes

- Haruka Saito

- Hayato Tanabe

- Akihiro Kudo

- Noritaka Machii

- Moritake Higa

- Satoshi Yamaguchi

- Gulinu Maimaituxun

- Kazumichi Abe

- Atsushi Takahashi

- Kenichi Tanaka

- Koichi Asahi

- Hiroaki Masuzaki

- Hiromasa Ohira

- Junichiro J. Kazama

- Michio Shimabukuro

8. Diagnostic Accuracy of FIB-4 and FIB-5 Scores as Compared to Fibroscan for Assessment of Liver Fibrosis in Patients With Non-Alcoholic Fatty Liver Disease

- Bandana Kumari

- Ramesh Kumar

- Sadhana Sharma

- Ayan Banerjee

- Visesh Kumar

- Pawan Kumar

- Neha Chaudhary

- Sushil Kumar

- Khushboo Raj

9. Liver Stiffness Measurement by Using Transient Elastography in Bangladeshi Patients with Type 2 Diabetes Mellitus and Ultrasonography-Diagnosed Nonalcoholic Fatty Liver Disease

- Muhammad Shah Alam

- ABM Kamrul-Hasan

- Syeda Tanzina Kalam

- SM Mizanur Rahman

- Mohammad Izazul Hoque

- Md. Belalul Islam

- Ajit Kumar Paul

10. Transient Elastography and Serum-Based Tests for Diagnosis of Fatty Liver and Advanced Fibrosis in a Community Cohort: A Cross-Sectional Analysis

- Michael H. Le

- Linda Henry

- Ramsey Cheung

- Mindie H. Nguyen

11. Elevated liver stiffness without histological evidence of liver fibrosis in rural Ugandans

- Martin Tibuakuu

- Caroline Jjingo

- Gregory Dale Kirk

- David Lee Thomas

- Ronald Gray

- Victor Ssempijja

- Fred Nalugoda

- David Serwadda

- Ponsiano Ocama

- Christopher Kenneth Opio

- David Erwin Kleiner

- Thomas Charles Quinn

- Steven James Reynolds

12. The Utility of Noninvasive Scores in Assessing the Prevalence of Nonalcoholic Fatty Liver Disease and Advanced Fibrosis in Type 2 Diabetic Patients

- Amandeep Singh

- Phuc Le

- Maajid M. Peerzada

- Rocio Lopez

- Naim Alkhouri

13. Liver Stiffness Measurement is Useful in Predicting Type 2 Diabetes Mellitus Among Nonalcohol Fatty Liver Disease Patients

- Yuping Ding

- Guiqiang Wang

- Quanjun Deng

- Mei Yang

- Jinghua Li

- Zuoyu Wang

- Haiyan Niu

- Shihai Xia

14. Efficacy of Lipid Ratios and Platelet Distribution Width for Assessment of Liver Fibrosis in Patients With Non-alcoholic Fatty Liver Disease

- Bandana Kumari

- Sadhana Sharma

- Ramesh Kumar

- Satish Dipankar

- Bijaya N Naik

- Ayan Banerjee

- Sushil Kumar

15. The ratio of high aspartate aminotransferase to alanine aminotransferase: an independent risk factor associated with poor prognosis in IgA nephropathy

- Hailang Wei

- Bingqing Liao

- Qi Zhou

- Xuhua Zhou

- Yue Zhong

- Yanbin Hao

- Fuhua Xie

- Runxiu Wang

16. Marine Chitooligosaccharide Alters Intestinal Flora Structure and Regulates Hepatic Inflammatory Response to Influence Nonalcoholic Fatty Liver Disease

- Jiayao Feng

- Yongjian Liu

- Jiajia Chen

- Yan Bai

- Jincan He

- Hua Cao

- Qishi Che

- Jiao Guo

- Zhengquan Su

17. Beneficial Effects of Tamarind Trypsin Inhibitor in Chitosan–Whey Protein Nanoparticles on Hepatic Injury Induced High Glycemic Index Diet: A Preclinical Study

- Ana J. F. C. Aguiar

- Jaluza L. C. de Queiroz

- Pedro P. A. Santos

- Christina S. Camillo

- Alexandre C. Serquiz

- Izael S. Costa

- Gerciane S. Oliveira

- Ana F. T. Gomes

- Lídia L. R. Matias

- Rafael O. A. Costa

- Thaís S. Passos

- Ana H. A. Morais

18. Predictors of Hepatic Fibrosis in Type 2 Diabetes Patients with Metabolic-Dysfunction-Associated Steatotic Liver Disease

- Joana D’Arc Matos França de Abreu

- Rossana Sousa Azulay

- Vandilson Rodrigues

- Sterffeson Lamare Lucena de Abreu

- Maria da Glória Tavares

- Flávia Coelho Mohana Pinheiro

- Clariano Pires de Oliveira Neto

- Caio Andrade

- Alexandre Facundo

- Adriana Guimarães Sá

- Patrícia Ribeiro Azevedo

- Ana Gregória Pereira de Almeida

- Debora Camelo de Abreu Costa

- Rogério Soares Castro

- Marcelo Magalhães

- Gilvan Cortês Nascimento

- Manuel dos Santos Faria

- Adalgisa de Souza Paiva Ferreira

19. Xiaoyaosan decoction alleviated rat liver fibrosis via the TGFβ/Smad and Akt/FoxO3 signaling pathways based on network pharmacology analysis

- Yuan Zhou

- Rong Wu

- Fei-Fei Cai

- Wen-Jun Zhou

- Yi-Yu Lu

- Hui Zhang

- Qi-Long Chen

- Shi-Bing Su

20. Liver Fibrosis Biomarker Validation Using Machine Learning Algorithms

- Min-Kyeong Kim

- Heon-Ju Kwon

- Kangsu Shin

- Hyosoon Park

- Hee-Yeon Woo

- Chang-Hun Park

- Min-Jung Kwon

21. FibroScan compared to liver biopsy for accurately staging recurrent hepatic steatosis and fibrosis after transplantation for MASH

- Laura Martínez‐Arenas

- Carmen Vinaixa

- Isabel Conde

- Sara Lorente

- Fernando Díaz‐Fontenla

- Patrice Marques

- Judith Pérez‐Rojas

- Eva Montalvá

- Ângela Carvalho‐Gomes

- Marina Berenguer

22. Telmisartan improves the metabolic, hematological and inflammasome indices in non-alcoholic fatty liver infiltration: A pilot open-label placebo-controlled study

- Marwan S.M. Al-Nimer

- Vian A.W. Esmail

- O. Mohammad

23. Phase angle as a severity indicator for liver diseases

- Ana Paula Pagano

- Juliana Maria Faccioli Sicchieri

- Isabela Laurencio Schiavoni

- Daniel Barbeiro

- Camila Sanches Manca

- Bruna Ramos da Silva

- Amanda Escobar Bezerra

- Lívia Cristina Mendonça Pinto

- Roberta Chaves Araújo

- Andreza Correa Teixeira

- Paula Garcia Chiarello

24. Significance of Correlation of Shear Wave Elastography With Fibrosis-4 in a Cohort of Patients With Diabetes and Nonalcoholic Fatty Liver Disease

- Rohan Kelkar

- Uday Phadke

- Raveena Kelkar

- Shalmi Khanapurkar

- Nishad A Barve

25. Liver Fibrosis Index-4 Does Not Correlate to Liver Elastography in Patients with Inflammatory Bowel Disease

- Iván Ferraz-Amaro

- Alejandro Hernández-Camba

- Marta Carrillo-Palau

- Noemi Hernández Álvarez-Buylla

- Antonia de Vera-González

- Alejandra González-Delgado

- Elena Heras-Recuero

- Miguel Á. González-Gay

26. Impact of Liver Fibrosis and Fatty Liver on T1rho Measurements: A Prospective Study

- Shuangshuang Xie

- Qing Li

- Yue Cheng

- Yu Zhang

- Zhizheng Zhuo

- Guiming Zhao

- Wen Shen

27. The utility of noninvasive scores in assessing the prevalence of nonalcoholic fatty liver disease and advanced fibrosis in type 1 diabetic patients

- Amandeep Singh

- Phuc Le

- Rocio Lopez

- Naim Alkhouri

28. The Fibrosis-4 Index Is Useful for Predicting Mortality in Patients with Pulmonary Hypertension due to Left Heart Disease

- Tetsuro Yokokawa

- Koichi Sugimoto

- Akiomi Yoshihisa

- Takuya Goto

- Tomofumi Misaka

- Masayoshi Oikawa

- Atsushi Kobayashi

- Takayoshi Yamaki

- Hiroyuki Kunii

- Kazuhiko Nakazato

- Takafumi Ishida

- Yasuchika Takeishi

29. Estimation of liver elasticity using the finite element method and four‐dimensional computed tomography images as a biomarker of liver fibrosis

- Koya Fujimoto

- Takehiro Shiinoki

- Yuki Yuasa

- Hidekazu Tanaka

30. Effects of TM6SF2 rs58542926 polymorphism on hepatocellular lipids and insulin resistance in early type 2 diabetes

- Kálmán Bódis

- Maria Bombrich

- Martin Schön

- Birgit Knebel

- Oana-Patricia Zaharia

- Gidon Bönhof

- Yanislava Karusheva

- Klaus Strassburger

- Yuliya Kupriyanova

- Jörg Kotzka

- Rainer Guthoff

- Vera Schrauwen-Hinderling

- Hadi Al-Hasani

- Volker Burkart

- Julia Szendroedi

- Robert Wagner

- Daniel F. Markgraf

- Michael Roden

31. Chinese herbal medicine mixture 919 syrup alleviates nonalcoholic fatty liver disease in rats by inhibiting the NF-κB pathway

- Manman Chen

- Jingwei Xing

- Danqing Pan

- Xiuhua Peng

- Pengfei Gao

32. Assessment of hepatic fibrosis and steatosis by vibration-controlled transient elastography and controlled attenuation parameter versus non-invasive assessment scores in patients with non-alcoholic fatty liver disease

- Ahmed M. F. Mansour

- Essam M. Bayoumy

- Ahmed M. ElGhandour

- Mohamed Darwish El-Talkawy

- Sameh M. Badr

- Ahmed El-Metwally Ahmed

33. Transcriptome analysis reveals the molecular mechanism of Yiqi Rougan decoction in reducing CCl4-induced liver fibrosis in rats

- Yu Xiong

- Jinyuan Hu

- Chen Xuan

- Jiayu Tian

- Kaiyue Tan

- Zhiwei Chen

- Yan Luo

- Xuqin Du

- Junxiong Cheng

- Lanyue Zhang

- Wenfu Cao

34. Correlation between Fibroscan and laboratory tests in non-alcoholic fatty liver disease/non-alcoholic steatohepatitis patients for assessing liver fibrosis

- Layal Al Nadaf

- Mohammed Hussein Kamareddine

- Emilie Fayad

- Aniqa Hussain

- Said Farhat

35. FIB-4, APRI, and AST/ALT ratio compared to FibroScan for the assessment of hepatic fibrosis in patients with non-alcoholic fatty liver disease in Bandar Abbas, Iran

- Behnaz Amernia

- Seyed Hamid Moosavy

- Fatemeh Banookh

- Ghazal Zoghi

36. Liver stiffness in 10 patients with non-alcoholic fatty liver disease before and after luseogliflozin administration

- Toshihiro Sato

37. Semaglutide for the treatment of non-alcoholic steatohepatitis: Trial design and comparison of non-invasive biomarkers

- Stephen A. Harrison

- Salvatore Calanna

- Kenneth Cusi

- Martin Linder

- Takeshi Okanoue

- Vlad Ratziu

- Arun Sanyal

- Anne-Sophie Sejling

- Philip N. Newsome

38. Recomendaciones en el tratamiento actual de la infección crónica por el virus de la hepatitis B

- Víctor Deioxes Escandón-Felizzola